+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relative bioavailability of rectally administered carbamazepine suspension in humans



Relative bioavailability of rectally administered carbamazepine suspension in humans



Epilepsia 26(5): 429-433



The relative bioavailability of an investigational carbamazepine suspension was studied following rectal administration in human volunteers. Carbamazepine, in doses of approximately 6 mg/kg, was given to nine men. The routes of administration were oral tablet, oral suspension, and rectal suspension. There was no significant difference (p greater than 0.05) in total absorption, maximum serum concentration, and time to achieve maximum serum concentration between the orally-administered tablet and the rectally administered suspension. Orally administered suspension was absorbed more quickly and completely. All volunteers complained of a strong defecatory urge after the suspension was given rectally. The slow absorption after rectal administration precludes the use of this route in status epilepticus; however, it may be a satisfactory alternative for maintenance therapy when administration by the oral route is not possible.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 006303604

Download citation: RISBibTeXText

PMID: 4043011


Related references

Bioavailability of rectally administered carbamazepine suspension in dogs. Epilepsia 24(5): 604-608, 1983

Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension. Clinical Drug Investigation 27(4): 243-250, 2007

Bioavailability of rectally administered carbamazepine mixture. British Journal of Clinical Pharmacology 24(6): 839-841, 1987

Bioavailability of rectally administered NPC 15669 from suppositories and an enema suspension. Pharmaceutical Research (New York) 9(10 Suppl. ): S272, 1992

Relative bioavailability of topiramate administered rectally. Epilepsy Research 54(2-3): 91-96, 2003

Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally. Pharmacotherapy 21(2): 158-162, 2001

Relative bioavailability of rectally administered phenobarbital sodium parenteral solution. Dicp 23(7-8): 565-568, 1989

Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension. Clinical Pharmacy 6(8): 646-649, 1987

Comparative bioavailability of theophylline its salts and derivatives administered rectally and of aminophylline administered orally in rabbits. Yakuzaigaku 45(2): 208-214, 1985

Relative bioavailability of atovaquone suspension when administered with an enteral nutrition supplement. Annals of Pharmacotherapy 32(10): 1004-1007, 1998

The bioavailability of rectally administered metoclopramide. Current Therapeutic Research 42(6): 1185-1188, 1987

Low bioavailability of rectally administered thalidomide. American Journal of Health-System Pharmacy 57(17): 1607-1610, 2000

Bioavailability of rectally administered naproxen. International Journal of Pharmaceutics 38(1-3): 117-122, 1987

The bioavailability of rectally administered morphine. Pharmacology & Toxicology 62(4): 203-205, 1988

Bioavailability of rectally administered lorazepam. Clinical Neuropharmacology 10(6): 555-559, 1987